SCHEMBL2808023

SCHEMBL2808023

CCC#Cc1cc(N)ccc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.45
CASP1 P29466 3/20 0.43
CYP3A4 P08684 3/20 0.41
TSHR P16473 2/20 0.41
PDE10A Q9Y233 1/20 0.36
KDM4E B2RXH2 4/20 0.36
MAPT P10636 3/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
RECQL P46063 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2E1 P05181 1/20 0.35
CYP2C8 P10632 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2A6 P11509 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2B6 P20813 1/20 0.35
CYP2C19 P33261 1/20 0.35
USP2 O75604 1/20 0.34
PLA2G7 Q13093 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25726913 0.85 CYP2C19 (0.50) ALDH1A1CASP1CYP3A4TSHRPDE10A
SCHEMBL2806220 0.82 ALDH1A1 (0.39) ALDH1A1CASP1CYP3A4TSHRPDE10A
SCHEMBL2808490 0.79 ALDH1A1 (0.52) ALDH1A1CASP1CYP3A4TSHRPDE10A
SCHEMBL2888200 0.74 PGK1 (0.33) CYP3A4CYP1A2CYP2E1CYP2C8CYP2D6
SCHEMBL2806709 0.73 ALDH1A1 (0.45) ALDH1A1CASP1CYP3A4TSHRPDE10A
SCHEMBL2812544 0.72 MAPT (0.55) ALDH1A1CASP1CYP3A4TSHRKDM4E
SCHEMBL61459 0.71 ALDH1A1 (0.57) ALDH1A1CASP1CYP3A4TSHRPDE10A
SCHEMBL31184930 0.71 ALDH1A1 (0.57) ALDH1A1CASP1CYP3A4TSHRPDE10A
SCHEMBL17653959 0.71 ALDH1A1 (0.52) ALDH1A1CASP1CYP3A4TSHRPDE10A
SCHEMBL2807960 0.71 ALDH1A1 (0.52) ALDH1A1CASP1CYP3A4TSHRPDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286353-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF FUJIFILM CORPORATION (JP) 2010-11-11 US disclosed
US-20100240908-A1 ACETYLENE COMPOUND FUJIFILM CORPORATION (JP) 2010-09-23 US disclosed
EP-2202221-A1 ACETYLENE COMPOUND Fujifilm Corporation (JP) 2010-06-30 EP disclosed
EP-2202220-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF Fujifilm Corporation (JP) 2010-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240908-A1 ACETYLENE COMPOUND NAT1, KATNA1, KAT2B ALDH1A1 401/4885CASP1 1288/4885CYP3A4 1909/4885
US-20100286353-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF KAT8, HDAC10, SSRP1 ALDH1A1 1480/4885CASP1 1789/4885CYP3A4 3918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.